Skip to main content
Top

Open Access 10-03-2025 | Hemofiltration | Original Article

Acid–base implications of the Gibbs-Donnan effect during continuous veno-venous hemofiltration

Authors: Francesco Zadek, Beatrice Brunoni, Francesca Mulazzani, Irene Sironi, Stefania Paccagnini, Maria Luisa De Angelis, Roberto Fumagalli, Thomas Langer

Published in: Journal of Nephrology

Login to get access

Abstract

Background

This in-vitro and in-vivo study investigates the Gibbs-Donnan effect across the filter during continuous veno-venous hemofiltration (CVVH). In particular, we assessed its acid–base implications, applying the physical–chemical approach.

Methods

A prospective, single-center study was conducted using the PrismaMax machine (Baxter). Two sets of in-vitro CVVH experiments (with and without albumin) were performed to quantify the Gibbs-Donnan effect. Electrolytes, glucose, and osmolarity changes were measured across the filter and in the ultrafiltrate. Strong ion difference and sieving coefficients of the main solutes were calculated. Similar measurements were performed in oligo-anuric critically ill patients undergoing CVVH.

Results

In-vitro experiments without albumin showed a sieving coefficient of 1 for both positive and negative ions. On the contrary, when albumin was added, the sieving coefficient for sodium and chloride changed linearly with albumin concentration (r = −0.94, p < 0.001 for sodium, r = 0.88, p < 0.001 for chloride), resulting in a progressive linear increase in post-filter strong ion difference (β = 1.1, r = 0.77, p = 0.003). In 22 studied patients, calculated albumin concentration increased across the filter (2.2 ± 0.5 g/dL vs. 3.1 ± 0.7 g/dL), leading to sodium retention (138 ± 6 vs. 141 ± 6 mmol/L, p < 0.001) and chloride excretion (100 ± 5 vs. 97 ± 5 mmol/L, p < 0.001), thus resulting in a higher post-filter strong ion difference (46 ± 4 vs. 40 ± 4 mmol/L, p < 0.001).

Conclusions

These in-vitro and in-vivo studies demonstrate that albumin linearly affects the sieving coefficient of ions, increasing the strong ion difference of plasma water during its passage through the filter and thus having a systemic alkalizing effect.

Graphic abstract

Appendix
Available only for authorised users
Literature
12.
go back to reference Sperelakis N (2011) Gibbs-Donnan Equilibrium Potentials. Elsevier Inc, Fourth Ed Sperelakis N (2011) Gibbs-Donnan Equilibrium Potentials. Elsevier Inc, Fourth Ed
27.
go back to reference Sherlock J, Ledwith J, Letteri J (1977) Hypoventilation and hypoxemia during hemodialysis: reflex response to removal of CO2 across the dialyzer. Trans Am Soc Artif Intern Organs 23:406–410CrossRefPubMed Sherlock J, Ledwith J, Letteri J (1977) Hypoventilation and hypoxemia during hemodialysis: reflex response to removal of CO2 across the dialyzer. Trans Am Soc Artif Intern Organs 23:406–410CrossRefPubMed
29.
go back to reference Zadek F, Danieli A, Brusatori S et al (2023) Combining the physical-chemical approach with standard base excess to understand the compensation of respiratory acid-base derangements: an individual participant meta-analysis approach to data from multiple canine and human experiments. Anesthesiology. https://doi.org/10.1097/aln.0000000000004751CrossRef Zadek F, Danieli A, Brusatori S et al (2023) Combining the physical-chemical approach with standard base excess to understand the compensation of respiratory acid-base derangements: an individual participant meta-analysis approach to data from multiple canine and human experiments. Anesthesiology. https://​doi.​org/​10.​1097/​aln.​0000000000004751​CrossRef
Metadata
Title
Acid–base implications of the Gibbs-Donnan effect during continuous veno-venous hemofiltration
Authors
Francesco Zadek
Beatrice Brunoni
Francesca Mulazzani
Irene Sironi
Stefania Paccagnini
Maria Luisa De Angelis
Roberto Fumagalli
Thomas Langer
Publication date
10-03-2025
Publisher
Springer International Publishing
Keyword
Hemofiltration
Published in
Journal of Nephrology
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-025-02238-0

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video